Filing metadata

Accession number
0001415889-25-008517
Form type
Form 4
Filer
Lyell Immunopharma, Inc.
CIK
CIK 1806952
Filed
Mar 18, 2025
Reporting period
Mar 17, 2025
Description
Insider transaction

Explore SEC Filings Hub